PharmiWeb.com - Global Pharma News & Resources
08-Jul-2019

Opioids Market to reach USD 29,535.80 Million by 2023 with Exponential CAGR 7.12% between 2018-2023

The Global Opioids Market is expected to reach USD 29,535.80 million by 2023 from USD 19,554.49 million in 2017 and is expected to register a CAGR of 7.12% during the forecast period of 2018 to 2023.

Introduction

Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties. They are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses.
The main purpose of opioids is to treat conditions inducing chronic pain such as cancers, arthritis, lower back pain, and fibromyalgia. The market for opioids is increasing due to the growing geriatric population, coupled with an increasing focus on palliative care and technological advancements in opioids. However, drug misuse and addiction are likely to hamper the market growth over the forecast period.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/14691

The global opioids market is growing at a rapid pace. The global opioids market is expected to reach USD 29,535.80 million by 2023 from USD 19,554.49 million in 2017 and is expected to register a CAGR of 7.12% during the forecast period of 2018 to 2023.
In 2017, the market was led by the Americas with a 77.49% share, followed by Europe, and Asia-Pacific with shares of 10.69% and 8.1%, respectively.
The market has been segmented based on product, application, and end-user.
The global opioids market on the basis of product has been segmented into immediate-release/short-acting opioid and extended-release/long-acting opioid. Immediate-release/short-acting opioid is further sub-segmented into codeine, oxycodone, hydrocodone, fentanyl, morphine, propoxyphene, and others. Extended-release/long-acting opioid is further sub-segmented into oxycodone, hydrocodone, methadone, fentanyl, morphine, oxymorphone, and others. The extended-release opioid segment accounted for the larger market share of 65.21% in 2017, with a market value of USD 12,750.91 million; it is expected to register a CAGR of 6.96% during the forecast period.
The global opioids market on the basis of application has been segmented into pain relief and anesthesia. Pain relief is further sub-segmented into cancer pain, postoperative pain management, low-back pain, orthopedic pain, neuropathic pain, and fibromyalgia. Anesthesia is further sub-segmented into cough suppression, diarrhea suppression, and de-addiction. The pain relief segment accounted for the largest market share of 38.09% in 2017, with a market value of USD 7,448.51 million; it is expected to register a CAGR of 6.28% during the forecast period.
The global opioids market on the basis of end user has been segmented into hospitals and clinics, pharmacies, academic research institutes, and others. The hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period.

Key Players

Sanofi SA, Pfizer Inc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd, Allergan Inc., Purdue Pharma L.P., West-Ward Pharmaceuticals Corporation, Sun Pharmaceutical Industries Ltd, Egalet Corporation, Janssen Global Services, LLC, Vertice Pharma LLC, and Mallinckrodt
Study Objectives
To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global opioids market
bull; To provide insights into factors influencing and affecting the market growth
bull; To provide historical and forecast revenue of market segments and sub-segments with respect to countries
bull; To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
bull; To provide economic factors that influence the global opioids market
bull; To provide a detailed analysis of the value chain and supply chain of the global opioids market

Target Audience

bull; Research and Development (Ramp;D) Companies
bull; Pharmaceutical Companies
bull; Government Research Institutes
bull; Academic Institutes and Universities
bull; Research Laboratories
bull; Hospitals and Clinics

Key Findings

bull; The global opioids market is expected to reach USD 29,535.80 million by 2023 at a CAGR of 7.12% from 2018 to 2023
bull; The Americas accounted for the largest market share of 77.49% in 2017, with a market value of USD 15,151.87 million; the market is expected to register a CAGR of 6.72% during the forecast period. Europe was the second-largest market in 2017, valued at USD 2,091.00 million; the market is projected to exhibit a CAGR of 7.34%. However, the market in Asia-Pacific is expected to register the highest CAGR of 10.34%.
bull; On the basis of end user, the hospitals and clinics segment accounted for the largest market share of 50.51% in 2017, with a market value of USD 9,876.99 million; it is expected to register a CAGR of 6.90% during the forecast period. The pharmacies segment was the second-largest market in 2017, valued at USD 4,368.80 million; it is projected to exhibit a CAGR of 7.31%. However, the academic research institutes segment is expected to register the highest CAGR of 7.53%.
bull; On the basis of application, the anesthesia segment was the second-largest market in 2017, valued at USD 4,082.84 million; the market is projected to register the highest CAGR of 7.94%.

Regional Analysis


bull; Americas
o North America
iuml;sbquo;sect; US
iuml;sbquo;sect; Canada
o Latin America
bull; Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
bull; Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
bull; Middle East amp; Africa
o Middle East
o Africa

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market/global-opioids-market-mrfr-14691

Table Of Contents:

Global Opioids Market Research Report Forecast to 2023

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Research Objective
2.4 Assumptions amp; Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.4.3 Market Structure
3 Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia
4.2.2 Favorable reimbursement policies for palliative care in developed regions
4.2.3 Substantial rise in road accidents, trauma, and surgical procedures
4.3 Restraints
4.3.1 Rising addiction and death cases due to overdose of opioid
4.4 Opportunities
4.4.1 Reconsideration of prescribing opioid analgesics due to rising awareness about opioids misuse, abuse, and overdose has prompted many stakeholders
5 Market Factor Analysis
5.1 Porterrsquo;s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Research amp;Development
5.2.2 Manufacturing
5.2.3 Distribution
5.2.4 Marketing amp; Sales
5.2.5 Post-Sales Monitoring
5.3 Demand amp; Supply: Gap Analysis
5.4 Pricing Analysis
6 Global Opioids Market, by Product
6.1 Overview
6.2 Extended-Release/Long-Acting Opioid
6.3 Immediate-Release/Short-Acting Opioid
7 Global Opioids Market, by Application
7.1 Overview
7.2 Pain Relief
7.3 Anesthesia
7.4 Cough Suppression
7.5 Diarrhoea Suppression
7.6 Deaddiction
8 Global Opioids Market, by End User
8.1 Overview
8.2 Hospitals amp; Clinics
8.3 Pharmacies
8.4 Academic Research Institutes
9 Global Opioids Market, by Region
9.1 Overview
9.2 Americas
9.2.1 North America
9.2.2 US
9.2.3 Canada
9.2.4 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.2 Germany
9.3.3 UK
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Rest of Western Europe
9.3.8 Eastern Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East amp; Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive Landscape
10.1 Company Market Share Analysis
10.1.1 Overview
11 Company Profile
11.1 Sanofi SA
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offered
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategy
11.2 Pfizer Inc
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offered
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategy
11.3 Boehringer Ingelheim GmbH
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offered
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategy
11.4 Teva Pharmaceutical Industries Ltd
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products/Services Offered
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategy
11.5 Allergan Inc.
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products/Services Offered
11.5.4 SWOT Analysis
11.5.5 Key Developments
11.5.6 Key strategy
11.6 Purdue Pharma L.P.
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products/Services Offered
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 West-Ward Pharmaceuticals Corporation
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products/Services Offered
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 Sun Pharmaceutical Industries Ltd
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products/Services Offered
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategy
11.9 Egalet Corporation
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products/Services Offered
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategy
11.1 Janssen Global Services, LLC
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products/Services Offered
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategy
11.11 Vertice Pharma LLC
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Products/Services Offered
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.11.6 Key Strategy
11.12 Mallinckrodt
11.12.1 Company Overview
11.12.2 Financial Overview
11.12.3 Products/Services Offered
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.12.6 Key Strategy
12 Appendix

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/14691

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 08-Jul-2019